Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-062967
Filing Date
2022-03-02
Accepted
2022-03-02 16:08:56
Documents
5
Effectiveness Date
2022-03-02

Document Format Files

Seq Description Document Type Size
1 S-8 d315651ds8.htm S-8 34663
2 EX-5.1 d315651dex51.htm EX-5.1 51428
3 EX-23.1 d315651dex231.htm EX-23.1 1716
4 EX-FILING FEES d315651dexfilingfees.htm EX-FILING FEES 16634
5 GRAPHIC g315651page8.jpg GRAPHIC 3031
  Complete submission text file 0001193125-22-062967.txt   109856
Mailing Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW 44 (0)20 8154 4600
Achilles Therapeutics plc (Filer) CIK: 0001830749 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263220 | Film No.: 22703496
SIC: 2836 Biological Products, (No Diagnostic Substances)